Effects of agmatine on nicotine-evoked behavioral responses in rats.
Journal Title: Pharmacological Reports - Year 2008, Vol 60, Issue 5
Abstract
Agmatine [2-(4-aminobutyl)guanidine], is a novel endogenous ligand at alpha(2)-adrenoceptors, imidazoline and N-methyl-D-asparate receptors, as well as a nitric oxide synthase inhibitor. The present study tested whether agmatine (5-40 mg/kg, sc) modulated the locomotor, sensitizing, and discriminative stimulus effects of nicotine in male Wistar rats. Agmatine (10-40 mg/kg) affected neither the basal locomotor activity, nor the nicotine (0.4 mg/kg, sc)-evoked hyperactivation. A challenge with saline or nicotine (0.4 mg/kg, sc) on day 10 to rats treated repeatedly (for 5 days) with nicotine (0.4 mg/kg, sc; and exposed to experimental chambers), resulted in the expression of nicotine-evoked conditioned hyperlocomotor response or behavioral sensitization. Given on day 10, agmatine at a dose of 40 mg/kg (but not 20 mg/kg) attenuated nicotine-induced conditioned hyperactivity. However, when this dose was administered to the nicotine-sensitized rats, agmatine failed to alter the effect of the challenge dose of nicotine. In rats trained to discriminate nicotine (0.4 mg/kg, sc) from saline in a two-lever water-reinforced fixed ratio 10 task, agmatine (20 or 40 mg/kg) did not substitute for the training dose of nicotine. In combination studies, pretreatment with agmatine (5-40 mg/kg) did not affect the nicotine (0.4 mg/kg) discrimination and the fixed dose of agmatine (20 mg/kg) did not change the effects of the lower doses of nicotine (0.05-0.2 mg/kg). Our pharmacological analyses indicate that agmatine does not affect the locomotor, sensitizing, or subjective effects of nicotine. However, these data do show an inhibitory effect of agmatine over the expression of nicotine-induced conditioned hyperlocomotion.
Authors and Affiliations
Magdalena Zaniewska, Andrew McCreary, Gulay Sezer, Edmund Przegaliński, Małgorzata Filip
Evaluation of the irritating influence of carane derivatives and their antioxidant properties in a deoxyribose degradation test.
Previous studies of the propranolol monoterpene derivative (-)-4-[2-hydroxy-3-(N-isopropylamino)-propoxyimino]-cis-carane hydrochloride (KP-23) and its diastereoisomers, KP-23R and KP-23S, demonstrated different effects...
X-linked inhibitor of apoptosis protein regulates human interleukin-6 in umbilical vein endothelial cells via stimulation of the nuclear factor-kappaB and MAP kinase signaling pathways.
X-linked inhibitior of apoptosis (XIAP) is known as a potent inhibitor of apoptosis, but more recently has been shown to also act as a modulator of the nuclear factor kB (NF-kappaB) signaling pathway. To investigate whet...
Molecular assessment of the potential combination therapy of cytokines with biphalin and AZT for Friend leukemia virus infection in vitro.
Biphalin, a dimeric enkephalin analog, is under investigation as a potential, long-lasting medication of pain associated with chronic diseases, like cancer or AIDS. The role of cytokines, and splenocytes in anti-Friend l...
Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids.
Dietary fish oil omega-3 fatty acids (n-3 PUFAs), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), protect against arrhythmia and sudden cardiac death using largely unknown mechanisms. EPA and DHA may...
Function of the hypothalamo-neurohypophysial system in rats with myocardial infarction is modified by melatonin.
Pineal and melatonin interactions with the hypothalamo-neurohypophysial system are well documented. In addition, vasopressin and oxytocin secretion are known to be part of the neuroendocrine response to chronic heart fai...